Role of the liver in the control of carbohydrate and lipid homeostasis

Diabetes and Metabolism

Volumn 30, Issue 5, 2004, Pages 398-408

  Postic, C ^a   Dentin, R ^a   Girard, J ^a  

^a INSTITUT COCHIN   (France)

Author keywords

Gene regulation; Glucose and insulin signaling; Glucose metabolism; Lipid synthesis; Liver; Mouse models; Transgenic and knockout

Indexed keywords

CARBOHYDRATE; ENZYME; FATTY ACID; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN; INSULIN; LIPID; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PGC1 ALPHA; UNCLASSIFIED DRUG;

ABSORPTION; CARBOHYDRATE INTAKE; CONCENTRATION (PARAMETERS); DIET; DISEASE COURSE; DISEASE MODEL; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; INGESTION; INSULIN RELEASE; INSULIN RESISTANCE; LIPOGENESIS; LIVER; LIVER FUNCTION; LIVER METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PROTEIN ANALYSIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STIMULATION; TIME; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

EID: 10644256593     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70133-7     Document Type: Review

References (91)

1. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care, 1992, 15, 318-68.
2. McGarry JD. What if Minkowski had been ageusic? An alternative on Diabetes. Science, 1992, 258, 766-70.
3. Nordlie RC, Foste JD, Lange AJ. Regulation of glucose production by the liver. Annu Rev Nutr, 1999, 19, 379-406.
4. Pilkis SJ, Granner DK. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Phys, 1992, 54, 885-909.
5. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 2001, 414, 799-806.
6. O'Brien RM, Granner DK. Regulation of gene expression by insulin. Physiol Rev, 1996, 76, 1109-61.
7. Taylor SI. Deconstructing Type 2 Diabetes. Cell, 1999, 97, 9-12.
8. Michael MD, Kulkarni RN, Postic C, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell, 2000, 6, 87-97.
9. Bruning JC, Michael M, Winney J, et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell, 1998, 2, 559-69.
10. Fisher SJ, Kahn CR. Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. J Clin Invest, 2003, 111, 463-8.
11. Cherrington AD, Edgerton D, Sindelar DK. The direct and indirect effects of insulin on hepatic glucose production in vivo. Diabetologia, 1998, 41, 987-96.
12. Ader M, Bergman RN. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol, 1990, 258, E1020-32.
13. Rebrin K, Steil GM, Getty L, Bergman RN. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes, 1995, 44, 1038-45.
14. Trinh KY, O'Doherty RM, Anderson P, Lange AJ, Newgard CB. Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem, 1998, 273, 31615-20.
15. Valera A, Pujol A, Pelegrin M, Bosch F. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA, 1994, 91, 9151-4.
16. Sun Y, Liu S, Ferguson S, et al. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem, 2002, 277, 23301-7.
17. Arion WJ, Lange AJ, Walls HE, Ballas LM. Evidence for the participation of independent translocation for phosphate and glucose 6-phosphate in the microsomal glucose-6-phosphatase system. Interactions of the system with orthophosphate, inorganic pyrophosphate, and carbamyl phosphate. J Biol Chem, 1980, 255, 10396-406.
18. Burchell A, Cain DI. Rat hepatic microsomal glucose-6-phosphatase protein levels are increased in streptozotocin-induced diabetes. Diabetologia, 1985, 28, 852-6.
19. Barzilai N, Rossetti L. Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. J Biol Chem, 1993, 268, 25019-25.
20. Massillon D, Barzilai N, Chen W, Hu M, Rossetti L. Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats. J Biol Chem, 1996, 271, 9871-4.
21. Mithieux G, Vidal H, Zitoun C, Bruni N, Daniele N, Minassian C. Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes, 1996, 45, 891-6.
22. Seoane J, Trinh K, O'Doherty RM, et al. Metabolic impact of adenovirus-mediated overexpression of the glucose-6-phosphatase catalytic subunit in hepatocytes. J Biol Chem, 1997, 272, 26972-7.
23. Aiston S, Trinh KY, Lange AJ, Newgard CB, Agius L. Glucose-6-phosphatase overexpression lowers glucose 6-phosphate and inhibits glycogen synthesis and glycolysis in hepatocytes without affecting glucokinase translocation. Evidence against feedback inhibition of glucokinase. J Biol Chem 1999, 274, 24559-66.
24. Lei KJ, Chen YT, Chen H, et al. Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus. Am J Hum Genet, 1995, 57, 766-71.
25. She P, Shiota M, Shelton KD, Chalkley R, Postic C, Magnuson MA. Mice without hepatic phosphoenolpyruvate carboxykinase maintain normal fasting plasma glucose values but have impaired lipid metabolism. 2000, 20, 6508-17.
26. She P, Burgess SC, Shiota M, et al. Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation. Diabetes, 2003, 52, 1649-54.
27. Hanson RW, Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem, 1997, 66, 581-611.
28. Yoon JC, Puigserver P, Chen G, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature, 2001, 413, 131-8.
29. Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature, 2003, 423, 550-5.
30. Hall RK, Yamasaki T, Kucera T, Waltner-Law M, O'Brien R, Granner DK. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J Biol Chem, 2000, 275, 30169-175.
31. Streeper RS, Svitek CA, Chapman S, Greenbaum LE, Taub R, O'Brien RM. A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin. J Biol Chem, 1997, 272, 11698-701.
32. Biggs WH, Meisenhelder J, Hunter T, Cavenee WK, Arden KC. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA, 1999, 96, 7421-6.
33. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature, 1999, 398, 630-4.
34. Foufelle F, Ferré P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J, 2002, 366, 377-91.
35. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest, 2002, 109, 1125-31.
36. Chakravarty K, Leahy P, Becard D, et al. Sterol regulatory element-binding protein-1c mimics the negative effect of insulin on phosphocnolpyruvate carboxykinase (GTP) gene transcription. J Biol Chem, 2001, 276, 34816-23.
37. Yamamoto T, Shimano H, Nakagawa Y, et al. SREBP-1 interacts with HNF-4alpha and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes. J Biol Chem, 2004, 279, 12027-35.
38. Inoue H, Ogawa W, Ozaki M, el al. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med, 2004, 10, 168-74.
39. Christ B, Yazici E, Nath A. Phosphatidylinositol 3-kinase and protein kinase C contribute to the inhibition by interleukin 6 of phosphoenolpyruvate carboxykinase gene expression in cultured rat hepatocytes. Hepatology, 2000, 31, 461-8.
40. Metzger S, Goldschmidt N, Barash V, et al. Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels. Am J Physiol, 1997, 273, E262-7.
41. Agius L, Peak M, Newgard CB, Gomez-Foix AM, Guinovart JJ. Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis. J Biol Chem, 1996, 271, 30479-86.
42. Wilson JE. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol, 2003, 206, 2049-57.
43. Girard J. Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes. Annu Rev Nutr, 1997, 17, 325-52.
44. Thorens B. Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am J Physiol, 1996, 270, G541-53.
45. Matschinsky FM. Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes, 1990, 39, 647-52.
46. Postic C, Shiota M, Magnuson MA. Cell-specific roles of glucokinase in glucose homeostasis. Recent Prog Horm Res, 2001, 56, 195-217.
47. Magnuson MA, She P, Shiota M. Gene-altered mice and metabolic flux control. J Biol Chem, 2003, 278, 32485-8.
48. Ferre T, Pujol A, Riu E, Bosch F, Valera A. Correction of diabetic alterations by glucokinase. Proc Natl Acad Sci USA, 1996, 93, 7225-30.
49. Hariharan N, Farrelly D, Hagan D, et al. Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight. Diabetes, 1997, 46, 11-6.
50. Niswender KD, Shiota M, Postic C, Cherrington AD, Magnuson MA. Effects of increased glucokinase gene copy number on blood glucose homeostasis and hepatic glucose metabolism. J Biol Chem, 1997, 272, 22570-2.
51. Ferre T, Riu E, Bosch F, Valera A. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J., 1996, 10, 1213-8.
52. Niswender KD, Postic C, Jetton TL, et al. Cell-specific expression and regulation of a glucokinase gene locus transgene. J Biol Chem, 1997, 272, 22564-9.
53. Shiota M, Postic C, Fujimoto Y, et al. Glucokinase gene locus transgenic mice are resistant to the development of obesity-induced type 2 diabetes. Diabetes, 2001, 50, 622-9.
54. Grimsby J, Sarabu R, Corbett WL, et al. Allosteric activators of glucokinase: potential role in diabetes therapy. Science, 2003, 301, 370-3.
55. Brocklehurst KJ, Payne VA, Davies RA, et al. Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators. Diabetes, 2004, 53, 535-41.
56. Taylor R, Price TB, Katz LD, Shulman RG, Shulman GI. Direct measurement of change in muscle glycogen concentration after a mixed meal in normal subjects. Am J Physiol, 1993, 265, E224-9.
57. Taylor R, Magnusson I, Rothman DL, et al. Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest, 1996, 97, 126-32.
58. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest, 1992, 90, 1323-7.
59. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med, 1990, 322, 223-8.
60. Ferrer JC, Favre C, Gomis RR, et al. Control of glycogen deposition. FEBS Lett, 2003, 546, 127-32.
61. Lawrence JC, Jr. Roach PJ. New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes, 1997, 46, 541-7.
62. Armstrong CG, Browne GJ, Cohen P, Cohen PT. PPP1R6, a novel member of the family of glycogen-targetting subunits of protein phosphatase 1. FEBS Lett, 1997, 418, 210-4.
63. Moorhead G, MacKintosh C, Morrice N, Cohen P. Purification of the hepatic glycogen-associated form of protein phosphatase-1 by microcystin-Sepharose affinity chromatography. FEBS Lett, 1995, 362, 101-5.
64. Printen JA, Brady MJ, Saltiel AR. PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism. Science, 1997, 275, 1475-8.
65. Crosson SM, Khan A, Printen J, Pessin JE, Saltiel AR. PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. J Clin Invest, 2003, 111, 1423-32.
66. O'Doherty RM, Jensen PB, Anderson P, et al. Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen. J Clin Invest, 2000, 105, 479-88.
67. Postic C, Shiota M, Niswender KD, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell specific gene knock-outs using cre recombinase. J Biol Chem, 1999, 274, 305-15.
68. Dentin R, Pégorier J-P, Benhamed F, et al. Hepatic Glucokinase is required for the Synergistic Action of ChREBP and SREBP-1c on Glycolytic and Lipogenic gene expression. J Biol Chem, 2004, 279, 20314-26.
69. Vaulont S, Vasseur-Cognet M, Kahn A. Glucose regulation of gene transcription. J. Biol. Chem, 2000, 275, 31555-8.
70. Towle HC, Kaytor EN, Shih HM. Regulation of the expression of lipogenic enzyme genes by carbohydrate. Annu Rev Nutr, 1997, 17, 405-33.
71. Prip-Buus C, Perdereau D, Foufelle F, Maury J, Ferre P, Girard J. Induction of fatty-acid-synthase gene expression by glucose in primary culture of rat hepatocytes. Dependency upon glucokinase activity. Eur J Biochem, 1995, 230, 309-15.
72. Foretz M, Guichard C, Ferré P, Foufelle F. Sterol regulatoy element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci, 1999, 96, 12737-42.
73. Foretz M, Pacot C, Dugail I, et al. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol, 1999, 19, 3760-8.
74. Magana MM, Osborne TF. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter. J Biol Chem, 1996, 271, 32689-94.
75. Magana MM, Koo SH, Towle HC, Osborne TF. Different sterol regulatory element-binding protein-1 isoforms utilize distinct co-regulatory factors to activate the promoter for fatty acid synthase. J Biol Chem, 2000, 275, 4726-33.
76. Koo SH, Dutcher AK, Towle HC. Glucose and insulin function through two distinct transcription factors to stimulate expression of lipogenic enzyme genes in liver. J Biol Chem, 2001, 276, 9437-45.
77. Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest, 1997, 99, 846-54.
78. Yahagi N, Shimano H, Hasty AH, et al. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem, 2002, 277, 19353-7.
79. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell, 2000, 6, 77-86.
80. Tobe K, Suzuki R, Aoyama M, et al. Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver. J Biol Chem, 2001, 276, 38337-40.
81. Ide T, Shimano H, Yahagi N, et al. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat Cell Biol, 2004, 6, 351-7.
82. Bécard D, Hainault I, Azzout-Marniche D, Bertry-Coussot L, Ferre P, Foufelle F. Adenovirus-mediated overexpression of sterol regulatory element binding protein-Ic mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes, 2001, 50, 2425-30.
83. Iynedjian PB, Jotterand D, Nouspikel T, Asfari, M, Pilot PR. Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon c-AMP system. J Biol Chem, 1989, 264, 21824-9.
84. Magnuson MA, Andreone TL, Printz RL, Koch S, Granner DK. Rat glucokinase gene: structure and regulation by insulin. Proc Natl Acad Sci, 1989, 86, 4838-42.
85. Rufo C, Teran-Garcia M, Nakamura MT, Koo SH, Towle HC, Clarke SD. Involvement of a unique carbohydrate-responsive factor in the glucose regulation of rat liver fatty-acid synthase gene transcription. J Biol Chem, 2001, 276, 21969-75.
86. Shih HM, Towle HC. Definition of the carbohydrate response element of the rat S14 gene. Evidence for a common factor required for carbohydrate regulation of hepatic genes. J Biol Chem, 1992, 267, 13222-8.
87. O'Callaghan BL, Koo SH, Wu Y, Freake HC, Towle HC. Glucose regulation of the acetyl-CoA carboxylase promoter PI in rat hepatocytes. J Biol Chem, 2001, 276, 16033-9.
88. Yamashita H, Takenoshita M, Sakurai M, et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci, 2001, 98, 9116-21.
89. Kawaguchi T, Takenoshita M, Kabashima T, Uyeda K. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci, 2001, 98, 13710-5.
90. Kabashima T, Kawaguchi T, Wadzinski BE, Uyeda K. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci, 2003, 100, 5107-12.
91. Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci, 2004, 101, 7281-6.